EVALUATION OF THE PERFORMANCE OF MASEF SCORE IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) UNDER A LIPID-LOWERING MEDICATION

被引：0
|
作者：
Martinez-Arranz, Ibon [1 ]
Banales, Jesus [2 ]
Alonso, Cristina [1 ]
Mayo, Rebeca [1 ]
Arrese, Marco [3 ]
Crespo, Javier [4 ]
Noureddin, Mazen [5 ]
机构：
[1] OWL Metabol, Derio, Spain
[2] Univ Basque Country, Donostia Univ Hosp, Biodonostia Res Inst, Leioa, Spain
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Marques Valdecilla Univ Hosp, Univ Cantabria, IDIVAL, Santander, Spain
[5] Houston Methodist Hosp, Houston, TX USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
821
引用
收藏
页码：S619 / S620
页数：2
相关论文
共 50 条
  • [21] REAL-WORLD OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) COMPENSATED CIRRHOSIS AT A LARGE ACADEMIC REFERRAL CENTER
    Slatter, Shadera
    Guillot, Jordan
    Williams, Christopher
    Watanabe, Alexandre
    Chaudhri, Eirum
    Zhang, Xiao
    Fernandes, Gail
    Ge, Jin
    Rudrapatna, Vivek
    HEPATOLOGY, 2024, 80 : S860 - S861
  • [22] LIPID INDUCED ENDOTHELIAL INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) PROMOTES LIVER INFLAMMATION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
    Guo, Qianqian
    Sano, Akitoshi
    Warasnhe, Khaled
    Hamdan, Feda
    Cao, Sheng
    Ibrahim, Samar
    HEPATOLOGY, 2024, 80 : S339 - S340
  • [23] METABOLOMIC AND LIPIDOMIC ANALYSIS OF PATIENTS WITH PRESUMED METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) TREATED WITH THE SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR MIRICORILANT
    Kowdley, Kris
    Noureddin, Mazen
    Parks, Elizabeth
    Botbyl, Jeffrey
    Monibas, Rafael Mayoral
    Wadekar, Subhagya
    Espinueva, Aprille
    Juneja, Kavita
    Schwab, Andrew
    Alkhouri, Naim
    HEPATOLOGY, 2024, 80
  • [24] Physicians' Use of a Gene Expression Test was Associated with Increased Utilization and Medication Adherence among Patients Prescribed Lipid-Lowering Therapy
    Parsons, Kelly
    Yau, May
    Markward, Nathan
    Elashoff, Michael
    Lazarro, Jennifer
    Monane, Mark
    CIRCULATION, 2012, 126 (21)
  • [25] Cardiovascular disease burden in patients with and without metabolic dysfunction-associated steatohepatitis: data from the unCoVer-MASH longitudinal cohort study
    Bugianesi, Elisabetta
    Mehta, Anurag
    Mangla, Kamal Kant
    Chandramouli, Abhishek Shankar
    Grau, Katrine
    Krarup, Niels
    Patel, Ahsan Shoeb
    JOURNAL OF HEPATOLOGY, 2024, 80 : S477 - S477
  • [26] Projected Cost Savings With Optimal Medication Adherence in Patients With Cardiovascular Disease Requiring Lipid-Lowering Therapy: A Multinational Economic Evaluation Study
    Cho, Jeong-Yeon
    Wilson, Fernando A.
    Chaikledkaew, Usa
    Chen, Yingyao
    Phrommintikul, Arintaya
    Diaz-Aguilera, Miguel Angel
    Chen, Zhenyue
    Kim, Kyoo
    Chaiyakunapruk, Nathorn
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (22):
  • [27] Design, synthesis, and biological evaluation of imidazo[4,5-b]pyridine mitochondrial uncouplers for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
    Salamoun, Joseph M.
    Krinos, Emily L.
    Foutz, Mary A.
    Hargett, Stefan R.
    Beretta, Martina
    Shrestha, Riya
    Hoehn, Kyle L.
    Santos, Webster L.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [28] TOLL- LIKE RECEPTOR ( TLR) 5 MEDIATES DELETERIOUS EFFECTS OF LIPID INJURY AND FIBROGENIC RESPONSES IN METABOLIC DYSFUNCTION- ASSOCIATED STEATOHEPATITIS ( MASH) AND CLINICAL OUTCOMES
    Li, Wenhao
    Loy, John
    Devalia, Kalpana
    Boot, James
    Mein, Chaz
    Fallowfield, Jonathan
    Kendall, Tim
    Ramos, Maria Jimenez
    Alazawi, William
    HEPATOLOGY, 2024, 80 : S51 - S52
  • [29] Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria
    Pennisi, Grazia
    Enea, Marco
    Romero-Gomez, Manuel
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Fracanzani, Anna Ludovica
    de Ledinghen, Victor
    George, Jacob
    Berzigotti, Annalisa
    Vigano, Mauro
    Sebastiani, Giada
    Cannella, Roberto
    Delamarre, Adele
    Di Maria, Gabriele
    Lange, Naomi F.
    Tulone, Adele
    Di Marco, Vito
    Camma, Calogero
    Petta, Salvatore
    HEPATOLOGY, 2024, 79 (04) : 912 - 925
  • [30] Metabolic profiling of adipose tissues in metabolic dysfunction-associated steatohepatitis (MASH): insights from lipidomic, proteomic, and epigenetic analyses in morbidly obese patients undergoing bariatric surgery
    Placed-Gallego, Cristina
    Manuel Jimenez-Aguilar, Juan
    Onoiu, Alina-Iuliana
    Cambra-Cortes, Vicente
    Jimenez-Franco, Andrea
    Martinez-Navidad, Cristian
    Castane, Helena
    Camps, Jordi
    Joven, Jorge
    JOURNAL OF HEPATOLOGY, 2024, 80 : S583 - S584
12345